Drug
Pegilodecakin
Pegilodecakin: highest development phase Phase 1, developed by Eli Lilly. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Eli Lilly
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pegilodecakin NCT03267732 | Phase 1 | Healthy Adult Subjects |
Latest
No recent events.
Follow Pegilodecakin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.